A new NIH grant will help researchers use eye-tracking to understand how deaf people process vocabulary and develop reading ...

A home study found German cockroaches shed endotoxins and allergens indoors—and roach elimination cut both sharply.

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

A 6-week individualized smoking cessation program led to greater quit rates among patients with RA when compared with usual care.

FWC will soon begin testing state management in Florida in 2026 and 2027 if NOAA Fisheries grants Florida an "exempted fishing permit." ...

A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research suggests.Experts found that ...

Screening is an effective tool for reducing the burden of cancer,” per Fred Hutch public health researcher Chris Li. “But it's a complex process with multiple steps." Unfortunately, many Americans are ...

Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that the U.S. Food and Drug ...